Chemokine dynamics after mRNA vaccination

Area of Science:

• Immunology
• Vaccinology

Background:

• Messenger RNA (mRNA) vaccines have become crucial for vaccine development, particularly since the COVID-19 pandemic.
• Effective vaccines require rapid and durable immune responses, influenced by chemokines, cytokines, and chemokine receptors.

Purpose of the Study:

• To investigate the regulation of chemokines, cytokines, and chemokine receptors following mRNA-based SARS-CoV-2 vaccination.
• To characterize the resulting immune cell profile and its correlation with vaccine efficacy.

Main Methods:

• Quantified SARS-CoV-2 neutralizing antibody titers using ELISA.
• Measured serum chemokine and cytokine levels via bead-based immunoassays at multiple time points post-vaccination.
• Analyzed chemokine receptor expression on immune cells using flow cytometry.

Main Results:

• mRNA-1273 vaccination increased levels of type 1 and type 2 cytokines, pro-inflammatory cytokines, and chemokines (CXCL9, CXCL10, CXCL11, CCL2, CCL4) within four days post-vaccination.
• Vaccination altered chemokine receptor expression on various immune cell subsets, including CD4 T cells, B cells, and monocytes.
• Elevated CXCR4 expression on RBD+ B cells correlated positively with high neutralizing antibody titers.

Conclusions:

• Demonstrated dynamic, cell-specific chemokine regulation early after mRNA booster vaccination.
• This chemokine modulation is crucial for inducing efficient innate and adaptive immune responses.
• Findings highlight the role of chemokines in the success of mRNA-based vaccines.